Thanks senti for the links to the MHRA guidance update. That’s what I thought, but didn’t see it.
BTW - for the second question that wasn’t answered; I think the Human Tissue Authority (HTA) license will be updated to show “export” after another inspection in conjunction with a marketing authorization for DCVax-L/Murcidencel in the UK, and Advent obtains a wholesale dealer license (wholesale distribution authorisation) (WDA) for Sawston.